Individualized selection of insulin therapy helps achieve glycaemic control in type 1 or type 2 diabetes mellitus

被引:0
|
作者
不详
机构
关键词
Diabetes mellitus; treatment; Insulin aspart; therapeutic use; Insulin detemir; Insulin glargine; Insulin glulisine; Insulin lispro; Insulin;
D O I
10.2165/00042310-200824050-00004
中图分类号
学科分类号
摘要
The development of rapid-acting and long-acting insulin analogues has advanced the treatment of diabetes mellitus. Insulin therapy usually is not required at the onset of type 2 diabetes, but becomes necessary when endogenous insulin production is no longer adequate. In type 1 diabetes, a basal-bolus regimen of insulin therapy is required from the time of diagnosis. © 2008 Adis Data Information BV. All rights reserved.
引用
收藏
页码:13 / 16
页数:3
相关论文
共 50 条
  • [31] Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog
    Young, Jason R.
    McAdam-Marx, Carrie
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2010, 3 : 65 - 80
  • [32] New insulin types in type 1 diabetes mellitus
    Mesa, Jordi
    MEDICINA CLINICA, 2015, 145 (02): : 70 - 75
  • [33] Coping strategies in Type 1 and Type 2 diabetes patients using insulin: the relationship with emotional wellbeing and glycaemic control
    Motovilin, O. G.
    Shishkova, Yu. A.
    Surkova, E., V
    DIABETES MELLITUS, 2015, 18 (04): : 41 - 47
  • [34] Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus
    Asrul Akmal Shafie
    Chin Hui Ng
    Yui Ping Tan
    Nathorn Chaiyakunapruk
    PharmacoEconomics, 2017, 35 : 141 - 162
  • [35] Insulin glulisine imparts effective glycaemic control in patients with Type 2 diabetes
    Rayman, Gerrard
    Profozic, Velimir
    Middle, Michelle
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (02) : 304 - 312
  • [36] Long-term glycaemic control with insulin glargine in Type 2 diabetes
    Kacerovsky-Bielesz, G
    Dressler, A
    Freunscht, R
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (02) : 184 - 191
  • [37] Weight and glycaemic control in type 2 diabetes: what is the outcome of insulin initiation?
    Watson, L.
    Wilson, B. P.
    Alsop, J.
    Kumar, S.
    DIABETES OBESITY & METABOLISM, 2011, 13 (09) : 823 - 831
  • [38] Rituximab Therapy for Insulin Allergy in Type-1 Diabetes Mellitus
    Declue, Cory E.
    Phillips, Elizabeth J.
    Prieto-Granada, Carlos
    Bao, Shichun
    AACE CLINICAL CASE REPORTS, 2024, 10 (04): : 140 - 143
  • [39] Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients
    Kubo, Sayaka
    Watada, Hirotaka
    Kawamori, Ryuzo
    JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (1-2) : 60 - 65
  • [40] Beneficial and Detrimental Effects of Intensive Glycaemic Control, with Emphasis on Type 2 Diabetes Mellitus
    Pauline Camacho
    Shailesh Pitale
    Carlos Abraira
    Drugs & Aging, 2000, 17 : 463 - 476